Italy’s Epsilon SGR, a joint venture between Eurizon Capital SGR and Banca Imi, has launched Epsilon Flessibile Azioni Euro Settembre 2020, an Italy domiciled fund which seeks returns through a flexible exposure to the eurozone equity markets. The fund will adopt a flexible management style which will be able to gain an exposure from 0% […]
Banca IMI, the unlisted investment banking arm of Intesa Sanpaolo, recorded a consolidated profit of €411.4m in the first nine months of 2014, up 5.4% compared with the same period in 2013. The result reflects the development of the total income which rose to €1.06bn (+5.6%), albeit a difficult market situation over the summer months, which […]
Italy’s pharmaceutical company Rottapharm has submitted the request for admission to the Mercato Telematico Azionario (MTA) of Borsa Italiana and filed the programme for its IPO.
Intesa Sanpaolo Group’s Banca IMI has posted total inflows of €685m in first half of 2013.
FinecoBank is the top equity market broker in Italy by volume, according to the latest half year report on regulated and MTF markets from Assosim, the Italian broker association.
Banca IMI, the corporate and investment banking division of Italy’s Intesa Sanpaolo, reported a 37.5% increase in net income to €401m at the end of the first half of the year, as well as a 51.3% increase in operating income.
Two Intesa Sanpaolo subsidiaries have taken over Epsilon Sgr, in readiness for a relaunch